New York State Common Retirement Fund
RLAY icon

New York State Common Retirement Fund’s Relay Therapeutics RLAY Stock Holding History

New York State Common Retirement Fund’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
58,935
+13,136
+29% +$191K ﹤0.01% 1706
2026
Q1 		$456K Hold
45,799
– – ﹤0.01% 1943
2025
Q4 		$387K Buy
45,799
+16,400
+56% +$117K ﹤0.01% 2050
2025
Q3 		$153K Hold
29,399
– – ﹤0.01% 2419
2025
Q2 		$102K Hold
29,399
– – ﹤0.01% 2631
2025
Q1 		$77K Hold
29,399
– – ﹤0.01% 2629
2024
Q4 		$121K Sell
29,399
-55,054
-65% -$300K ﹤0.01% 2513
2024
Q3 		$598K Buy
84,453
+47,754
+130% +$357K ﹤0.01% 1874
2024
Q2 		$239K Buy
36,699
+21
+0.1% +$143 ﹤0.01% 2350
2024
Q1 		$304K Hold
36,678
– – ﹤0.01% 2276
2023
Q4 		$404K Buy
36,678
+1,127
+3% +$9.51K ﹤0.01% 2180
2023
Q3 		$299K Buy
35,551
+358
+1% +$3.85K ﹤0.01% 2247
2023
Q2 		$442K Sell
35,193
-20,723
-37% -$258K ﹤0.01% 2139
2023
Q1 		$921K Sell
55,916
-12,431
-18% -$223K ﹤0.01% 1894
2022
Q4 		$1.02M Sell
68,347
-19
-0% -$364 ﹤0.01% 1961
2022
Q3 		$1.53M Buy
68,366
+4,973
+8% +$109K ﹤0.01% 1747
2022
Q2 		$1.06M Buy
63,393
+11,089
+21% +$238K ﹤0.01% 1986
2022
Q1 		$1.56M Buy
52,304
+8,612
+20% +$209K ﹤0.01% 1871
2021
Q4 		$1.34M Buy
43,692
+492
+1% +$15.5K ﹤0.01% 1985
2021
Q3 		$1.36M Sell
43,200
-7,393
-15% -$249K ﹤0.01% 1975
2021
Q2 		$1.85M Buy
50,593
+13,293
+36% +$438K ﹤0.01% 1917
2021
Q1 		$1.29M Buy
37,300
+8,100
+28% +$352K ﹤0.01% 2013
2020
Q4 		$1.21M Hold
29,200
– – ﹤0.01% 1951
2020
Q3 		$1.24M Buy
+29,200
New +$1.11M ﹤0.01% 1802

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

New York State Common Retirement Fund's RLAY Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Relay Therapeutics (RLAY) stake by 29% in Q2 2026, buying an estimated $191K and bringing the position to 58,935 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1706.

New York State Common Retirement Fund first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.85M in Q2 2021. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • New York State Common Retirement Fund held 58,935 shares of Relay Therapeutics worth $1.1M as of Q2 2026.
  • New York State Common Retirement Fund bought 13,136 Relay Therapeutics shares in Q2 2026, an estimated $191K.
  • Relay Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1706 holding.
  • New York State Common Retirement Fund first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • New York State Common Retirement Fund's Relay Therapeutics position peaked at $1.85M in Q2 2021.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.